Who invested in InteKrin

4 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$65Mraised across 4 rounds since 2007, from 4 sources

$23MSeries B$19MSeries C$21MVenture$2.3MVenture

Latest round: Venture, $2.3MJun 2010
Biggest round: $23MSeries B · Jan 2007
Investors: 7

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2007200820092010

$23MSeries B$19MSeries C$21MVenture$2.3MVenture

First round: Series B, $23M
Biggest round: $23M
Usual gap between rounds: 14 months

The rounds

Jun 2010
Venture$2.3M
No investor was named in the report.
From a historical funding record
Apr 2009
Venture$21M
No investor was named in the report.
From a historical funding record
Aug 2008
Series C$19M2 new5 returning
Reported by deals.venturebeat.com
Jan 2007
Series B$23M5 new
From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2007Series C2008Venture2009Venture2010

OrbiMed

Sofinnova Investments

Asset Management Ventures

Vivo VenturesSears Capital Management

Skyline VenturesAmgen

Everyone who backed them

OrbiMedPrivate equity2rounds

Sofinnova InvestmentsVC firm2rounds

Asset Management VenturesVC firm2rounds

Vivo VenturesVC firm2rounds

Sears Capital ManagementInvestment firm2rounds

Skyline VenturesVC firm1round

AmgenCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about InteKrin

Who invested in InteKrin?

InteKrin's investors include OrbiMed, Sofinnova Investments, Asset Management Ventures, Vivo Ventures and Sears Capital Management, and 2 more on record.